You are here

Glycan Therapeutics LLC

Company Information
Address
617 Hutton St Ste 101
Raleigh, NC 27606-6330
United States



Information

DUNS: 078778864

# of Employees: 5


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Diverse Heparan Sulfate Oligosaccharide Libraries For Understanding and Therapeutically Manipulating Glycosaminoglycans

    Amount: $1,229,662.00

    Heparan sulfate (HS) is a highly sulfated polysaccharide with important roles in many physiological and pathological events. The structural diversity of naturally existing HS, which exhibits diverse s ...

    SBIRPhase II2020Department of Health and Human Services National Institutes of Health
  2. Developing Heparan Sulfate Glycan Array

    Amount: $1,443,680.00

    This SBIR phase II proposal is aimed at developing microarray technology to study the interactions between heparan sulfate (HS) and proteins. HS is a highly sulfated polysaccharide displaying a wide r ...

    SBIRPhase II2020Department of Health and Human Services National Institutes of Health
  3. Development of a New Carbohydrate-based Anticoagulant Drug

    Amount: $2,493,273.00

    Low molecular weight heparins (LMWHs) are partially depolymerized natural products of heparin, which are isolated from porcine intestine. A worldwide distribution of contaminated heparin in 2007 was a ...

    SBIRPhase II2019Department of Health and Human Services National Institutes of Health
  4. LC-MS System to Determine the Molecular Mass of Synthesized Heparan and Chondroitin Sulfate Oligosaccharides

    Amount: $1,599,559.00

    This fast-track STTR application proposes to synthesize structurally defined heparan sulfate and chondroitin sulfate oligosaccharides for biological research. Glycan Therapeutics is a biotech company ...

    STTRPhase II2019Department of Health and Human Services National Institutes of Health
  5. Diverse Heparan Sulfate Oligosaccharide Libraries For Understanding and Therapeutically Manipulating Glycosaminoglycans

    Amount: $536,791.00

    Heparan sulfateHSis a highly sulfated polysaccharide with important roles in many physiological and pathological eventsThe structural diversity of naturally existing HSwhich exhibits diverse sulfation ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  6. Reactor for Insect Cell Culture

    Amount: $334,239.00

    This fast track STTR application proposes to synthesize structurally defined heparan sulfate and chondroitin sulfate oligosaccharides for biological researchGlycan Therapeutics is a biotech company sp ...

    STTRPhase I2018Department of Health and Human Services National Institutes of Health
  7. Developing Heparan Sulfate Glycan Array

    Amount: $296,746.00

    Project titleDeveloping heparan sulfate glycan array This proposal is aimed at developing a high throughput method to study the interactions between heparan sulfateHSand proteinsHS is a highly sulfate ...

    STTRPhase I2017Department of Health and Human Services National Institutes of Health
  8. Development of a New Carbohydrate based Anticoagulant Drug

    Amount: $224,698.00

    Low molecular weight heparins LMWHs a commonly used anticoagulant drug in the hospitals are carbohydrate based molecules Heparin is isolated from porcine intestine through a long and unreliable s ...

    STTRPhase I2017Department of Health and Human Services National Institutes of Health
  9. CHEMOENZYMATIC SYNTHESIS OF HEPARAN SULFATE OLIGOSACCHARIDES

    Amount: $693,710.00

    The goal of this contract is to synthesize a heparan sulfate HS library consisting of structurally homogeneous oligosaccharides in response to an SBIR contract call from NCl Chemically Defined ...

    SBIRPhase II2015Department of Health and Human Services National Institutes of Health
  10. CHEMOENZYMATIC SYNTHESIS OF HEPARIN SULFATE OLIGOSACCARIDES

    Amount: $299,447.00

    The goal of this application is to synthesize heparan sulfate (HS) library consisting of structurally homogeneous oligosaccharides, in response to a SBIR contract call from NCI- 321 Chemically Define ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government